Cues given off by unfertilised female mussel eggs act as a genetically compatible chemoattractant to sperm. [ + ]

The Queensland Government will kick another $1m into the Medical Research Commercialisation Fund (MRCF), a VC fund jointly supported by the federal, Qld, Vic, NSW and WA governments. [ + ]

Nexvet Biopharma will put the proceeds of a $33.6m Series B financing round to funding key clinical trials for its lead products, as well as expanding its development pipeline and US presence. [ + ]

The Therapeutic Goods Administration (TGA) has announced a review of the low value turnover exemption scheme (LVT scheme), which exempts cost recovery fees on products with low turnover. [ + ]

Innate Immunotherapeutics (ASX:IIL) expects to start recruiting up to 90 secondary progressive multiple sclerosis patients for a phase IIb trial of MIS416 in June. [ + ]

Fairfax Media has published an article claiming that science body CSIRO is bracing for a May budget cut of up to $150 million, or more than 20% of its total government funding, with the organisation's top executive team modelling a range of scenarios based around this outcome. [ + ]

ResMed (ASX:RMD) has secured Red Dot designation for a nasal pillow mask and a soon-to-be-launched life support ventilator at this year's awards. [ + ]

Merck Millipore, the life science division of Merck, has announced the appointment of Dr Udit Batra as its incoming president and CEO. Dr Batra comes to Merck Millipore from the consumer health division of Merck KGaA, where he successfully grew the business in established and emerging markets. [ + ]

Researchers from the University of Zurich and ETH Zurich have discovered a piece in the puzzle which explains how the inheritance of traumas may be mediated. [ + ]

The US FDA has set a PDUFA date of 26 September for pSivida (ASX:PVA) partner Alimera Sciences' fourth new drug application for diabetic macular edema treatment Iluvien.

This year's Agricultural Biotechnology International Conference (ABIC) has launched its program. Registrations are now open for the event, to be held from 5-8 October in Saskatoon, Saskatchewan, Canada. [ + ]

A leading British scientist, Professor Sir Philip Cohen FAA FRS FRSE, has been announced as a Corresponding Member of the Australian Academy of Science. [ + ]

A delegation of seven professors from Australian universities recently travelled to China to promote joint research in the musculoskeletal disciplines. [ + ]

Qiagen has acquired an exclusive worldwide licence to the biomarker calreticulin (CALR), whose mutations are found in an estimated 15% of cases of myeloproliferative neoplasms (MPNs) - a group of blood disorders involving overproduction of blood cells. [ + ]

UQ spinoff Spinifex has raised $47.7m in series C investment funding to help accelerate the clinical development of neuropathic and inflammatory pain drug EMA401. [ + ]